Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
